
Investing.com • 6h ago
Nvidia, QIA-backed Iambic Therapeutics files for US IPO as biotech boom rolls on
1 sources • 1

Rice University • 21d ago
Rice-developed BuoyBeads bring biotechnology lessons to high school classrooms
1 sources • 1

US Top News and Analysis (US) • 18d ago
The personal investment firms of titans like Stanley Druckenmiller are backing innovations in gene editing, drug discovery and more.
1 sources • 1

Investing News Network • 6d ago
AbbVie and BioLabs University of Toronto Open Applications for AbbVie Biotech Innovators Award at Life Sciences Ontario Forum
1 sources • 1

House.gov • 12d ago
Babin, McCormick Seek Information on Federal Biotechnology Research and Security
1 sources • 1

euractiv.com • 11d ago
Spain pushes for ‘access toolbox’ in EU biotech rules
1 sources • 1

Snow Report Southern Africa • 16d ago
Big pharma eyes Australian biotech as $300b patent cliff looms
1 sources • 1

Technology Networks • 7d ago
mRNA Nanoparticles Could Reprogram the Tumor Microenvironment
1 sources • 1

HackerNoon • 12d ago
How AI is Accelerating the Growth of Biotech into a $31.87 Trillion Global Industry
1 sources • 1

Axios • 10d ago
Axios Live: Research and manufacturing investments boost Philadelphia's biotech role
1 sources • 1
International bodies adopt new oversight standards governing biotech & genetics.
Major civic and legislative bodies update standards for biotech & genetics accountability.
Civil society coalitions demand open reporting and multi-source oversight.
Initial policy precedents set the baseline for modern biotech & genetics discourse.
Pioneering legislative action establishes foundational public protections.
Stories today
39
Total sources
46
Across topic coverage
Avg. bias score
0.00
Center
Most coverage
Biotech & Genetics
39 stories
Breaking now
0
Live updates